Tumor necrosis factor-␣ (TNF-␣) inhibits osteoblast function in vitro by inhibiting collagen deposition. Studies generally support that TNF-␣ does not inhibit collagen biosynthesis by osteoblasts but that collagen deposition is in some way diminished. The study investigated TNF-␣ regulation of biosynthetic enzymes and proteins crucial for posttranslational extracellular collagen maturation in osteoblasts including procollagen C-proteinases, procollagen C-proteinase enhancer, and lysyl oxidase. The working hypothesis is that such regulation could inhibit collagen deposition by osteoblasts. We report that in phenotypically normal MC3T3-E1 osteoblasts, TNF-␣ decreases collagen deposition without decreasing collagen mRNA levels or procollagen protein synthesis. Analyses of the cell layers revealed that TNF-␣ diminished the levels of mature collagen cross-links, pyridinoline and deoxypyridinoline. Further analyses revealed that the mRNA expression for lysyl oxidase, the determining enzyme required for collagen cross-linking, is downregulated by TNF-␣ in a concentration-and time-dependent manner by up to 50%. The decrease was accompanied by a significant reduction of lysyl oxidase protein levels and enzyme activity. By contrast, Northern and Western blotting studies revealed that procollagen C-proteinases bone morphogenic protein-1 and mammalians Tolloid and procollagen C-proteinase enhancer were expressed in MC3T3-E1 cells and not down-regulated. The data together demonstrate that TNF-␣ does not inhibit collagen synthesis but does inhibit the expression and activity of lysyl oxidase in osteoblasts, thereby contributing to perturbed collagen cross-linking and accumulation. These studies identify a novel mechanism in which proinflammatory cytokine modulation of an extracellular biosynthetic enzyme plays a determining role in the control of collagen accumulation by osteoblasts.
TNF-␣1 is an inflammatory cytokine produced primarily by monocytes and macrophages and also by a variety of mesenchymal cells. TNF-␣ levels are elevated in various bone disorders such as rheumatoid arthritis, osteoporosis, and periodontitis (1-4). In bone tissue, TNF-␣ inhibits osteoblast function and increases osteoclastogenesis, thus favoring net matrix destruction (5, 6) and the collagenous matrix structure is disrupted by TNF-␣ (7-9). Reports indicate that TNF-␣ somehow inhibits collagen deposition while having little effect on collagen synthesis, although the mechanisms that contribute to this phenomenon have not been elucidated (6, 7).Type I collagen is the major structural protein in the extracellular matrix of bone tissue. Normal collagen structure and the balance between production, deposition, and degradation of collagen are important in the development and maintenance of skeletal tissue (1). Collagen biosynthesis is a multistep process that involves intracellular posttranslational modifications, assembly of procollagen chains, secretion, extracellular processing, and cross-linking to form a mature functional matrix (10). The mechanisms...